1. Introduction {#sec1-biomedicines-08-00003}
===============

Cinnamon plants (*Cinnamomum* spp.) are of the genus Lauraceae, native to South and Southeast Asia, and are generally used as food flavors and traditional medicinal plants. *Cinnamomum osmophloeum*, commonly known as indigenous cinnamon or pseudocinnamon, is endemic to Taiwan's natural hardwood forests \[[@B1-biomedicines-08-00003]\]. Major components of the essential oils extracted from *C. osmophloeum* leaves explored by high-performance liquid chromatography (HPLC) are as follows: α-pinene, camphene, benzaldehyde, β-pinene, 3-pheayl pionaldehyde, *cis*-cinnamaldehyde, *trans*-cinnamaldehyde, isobornylacetate, eugenol, and cinnamil acetate \[[@B2-biomedicines-08-00003]\]. The essential oils extracted from *C. osmophloeum* leaves comprise 101 volatile compounds, as identified by GC/MS analysis, including monoterpenoids, sesquiterpenoids, alcohols, phenols, aldehydes, ketones, esters, acids, and other miscellaneous compounds. It was demonstrated that the linalool chemotypes present in *C. osmophloeum* were as follows: linalool, trans-cinnamyl acetate, camphor, cinnamaldehyde, 3-phenyl-2-propenal, caryophyllene, coumarin, bornyl acetate, limonene, α-(+)-pinene, estragole, and caryophyllene oxide \[[@B3-biomedicines-08-00003]\]. In several studies (both in vitro and in vivo), *C. osmophloeum* has been applied as an alternative natural therapy to treat certain compromised and uncompromised diseases \[[@B3-biomedicines-08-00003],[@B4-biomedicines-08-00003],[@B5-biomedicines-08-00003],[@B6-biomedicines-08-00003],[@B7-biomedicines-08-00003]\].

Oral mucositis (OM) is known as the inflammation of oral mucosa, usually occurring as an adverse side-effect of chemotherapy and/or radiation therapy (radiotherapy), and is manifested as atrophy, swelling, erythema, and ulceration \[[@B8-biomedicines-08-00003]\]. OM occurrence in the hospital might increase costs and deteriorate oral health quality of life \[[@B9-biomedicines-08-00003],[@B10-biomedicines-08-00003],[@B11-biomedicines-08-00003]\]. Hence, oral care treatments, including nutritional care, pain control, oral cleansing, palliation of a dry mouth, bleeding handling, and medicinal interventions have been introduced to decrease the severity of OM after cancer therapy \[[@B12-biomedicines-08-00003]\]. Patients receiving radiotherapy to head and neck areas are at a significant risk of developing oral mucositis. The risk is lower (less than 50% or little risk) in patients with prolonged chemotherapy, patients receiving surgery, and patients with radiotherapy to non-head and neck areas \[[@B10-biomedicines-08-00003],[@B13-biomedicines-08-00003]\]. The underlying pathophysiology of OM is divided into five phases: (1) initiation, (2) primary damage response, (3) signaling and amplification, (4) ulceration (symptomatic phase), and (5) healing \[[@B14-biomedicines-08-00003],[@B15-biomedicines-08-00003],[@B16-biomedicines-08-00003]\]. The first phase (initiation stage) happens after exposure to radiotherapy or chemotherapy. It consists of two events: DNA breakdown and the generation of reactive oxygen species (ROS). DNA strand breakdowns lead to direct injury and death of the cells, and reactive oxygen species play a role as key initiators and mediators of downstream biological events. During the second phase (primary damage response), activator transduction pathways are stimulated by the DNA breaks strand, which can lead to the activation of several transcription factors, including p53 and nuclear factor kappa-B (NF-κB). NF-κB works as a controller for the expression of a broad range of genes, and produces a series of mediators, including pro-inflammatory cytokines and both pro- and anti-apoptotic cellular changes. During phase III (signal amplification stage), pro-inflammatory cytokines deliver a positive reaction to enhance and accelerate the process of wound healing. During phase IV (ulceration phase, also called symptomatic phase), it is common for the mucosal surface to become re-infected with bacteria. Bacterial invasion stimulates macrophage accumulation to conceal additional amounts of pro-inflammatory cytokines. During phase V (healing stage), signals from the connective tissue to the bordering epithelium can activate the migration, propagation, and differentiation of cells, resulting in healed mucosa. A number of biomaterials explored for OM therapy perform their principal mechanisms linked to pathophysiology by depressing pro-inflammatory cytokines. In addition to anti-inflammation, antioxidant, antifungal, antibacterial, and immunomodulator mechanisms of action have been reported \[[@B17-biomedicines-08-00003]\]. As one of the encouraging biomaterials, *C. osmophloeum* might be a potential alleviator of OM.

Previous studies on cinnamon have been limited to *C. osmophloeum* \[[@B1-biomedicines-08-00003]\]. However, different species of cinnamon might possess diverse beneficial biological activities aiming at various medical therapies. Therefore, we have provided an updated extensive overview on studies of the medical-biological activities of *C. osmophloeum* and its principal ingredients, both in vitro and in vivo. The potential use of this natural component in oral mucositis therapy is also discussed.

2. Materials and Methods {#sec2-biomedicines-08-00003}
========================

A computerized search for the reported works was performed through PubMed^®^, Scopus, ScienceDirect, and Web of Science databases by using the key words "*cinnamon osmophloeum*", "*indigenous cinnamon*", and "*pseudocinnamon*". A systematic review was conducted following PRISMA. In order to identify the potential use of *C. osmophloeum* in the alleviation of OM, additional sources were identified through cross-referencing.

In addition, previously published review articles were searched to gain additional information. In order to identify the potential use of *C. osmophloeum* in the alleviation of OM induced by radiotherapy and/or chemotherapy, a second computerized search using PubMed^®^, Scopus, ScienceDirect, and Web of Science databases was carried out by utilizing keywords with *C. osmophloeum* constituents that possess anti-inflammation, antioxidant, and antibacterial activities with OM, including "*cinnamaldehyde* + *oral mucositis*", "*trans-cinnamaldehyde* + *oral mucositis*", "*kaempferitin* + *oral mucositis*", "*kaempferol* + *oral mucositis*", "*cinnamic acid* + *oral mucositis*", "*cinnamyl alcohol* + *oral mucositis*", "*cinnamyl acetate* + *oral mucositis*", "a*lloaromadendrene* + *oral mucositis*", and "*linalool* + *oral mucositis*".

3. Results and Discussion {#sec3-biomedicines-08-00003}
=========================

3.1. Medical-Biological Activities of C. osmophloeum {#sec3dot1-biomedicines-08-00003}
----------------------------------------------------

A set of 51 articles related to *C. osmophloeum* was identified, in which 18 articles were excluded because they were duplicate papers (*n* = 2), were not related to the beneficial biological activities (*n* = 2), or were irrelevant articles (*n* = 14). Irrelevant articles involved studies not related to medical uses, studies related to mushroom planting in *C. osmophloeum*, and review article(s) ([Figure 1](#biomedicines-08-00003-f001){ref-type="fig"}). Specific studies (2 to 4) discussed the beneficial biological activities \[[@B3-biomedicines-08-00003],[@B18-biomedicines-08-00003],[@B19-biomedicines-08-00003],[@B20-biomedicines-08-00003],[@B21-biomedicines-08-00003],[@B22-biomedicines-08-00003]\] and suggested more than one chemical compound as the active content. Some beneficial biological activities have been summarized in [Table 1](#biomedicines-08-00003-t001){ref-type="table"} and consist of anti-inflammatory activities \[[@B20-biomedicines-08-00003],[@B22-biomedicines-08-00003],[@B23-biomedicines-08-00003],[@B24-biomedicines-08-00003],[@B25-biomedicines-08-00003],[@B26-biomedicines-08-00003],[@B27-biomedicines-08-00003],[@B28-biomedicines-08-00003],[@B29-biomedicines-08-00003],[@B30-biomedicines-08-00003]\], wound repair activities \[[@B20-biomedicines-08-00003]\], antibacterial activities \[[@B31-biomedicines-08-00003],[@B32-biomedicines-08-00003]\], antifungal activities \[[@B33-biomedicines-08-00003],[@B34-biomedicines-08-00003]\], antioxidant activities \[[@B18-biomedicines-08-00003],[@B20-biomedicines-08-00003],[@B35-biomedicines-08-00003],[@B36-biomedicines-08-00003],[@B37-biomedicines-08-00003]\], anti-hyperglycemic activities \[[@B3-biomedicines-08-00003],[@B18-biomedicines-08-00003],[@B21-biomedicines-08-00003]\], antidyslipidemia activities \[[@B38-biomedicines-08-00003],[@B39-biomedicines-08-00003]\], anti-cancer and anti-tumor activities \[[@B22-biomedicines-08-00003]\], renal disease therapy, and anti-hyperuricemia activities \[[@B2-biomedicines-08-00003],[@B4-biomedicines-08-00003]\]. In addition, studies on the leaves, twigs, barks, heartwoods, and roots of *C. osmophloeum* were also reported.

It was conveyed that *C. osmophloeum* comprised six chemotypes; cinnamaldehyde, cinnamaldehyde/cinnamyl acetate, cinnamyl acetate, linalool, camphor, and mixed types ([Table 2](#biomedicines-08-00003-t002){ref-type="table"}). The chemical structures of cinnamaldehyde, cinnamyl acetate, linalool, and camphor are given in [Figure 2](#biomedicines-08-00003-f002){ref-type="fig"}. Most of the studies showed that the dominant chemical contents of the cinnamaldehyde type were cinammaldehyde/*trans*-cinnamaldehyde \[[@B2-biomedicines-08-00003],[@B29-biomedicines-08-00003],[@B31-biomedicines-08-00003],[@B32-biomedicines-08-00003],[@B33-biomedicines-08-00003],[@B34-biomedicines-08-00003],[@B36-biomedicines-08-00003],[@B37-biomedicines-08-00003],[@B47-biomedicines-08-00003],[@B48-biomedicines-08-00003]\], benzaldehyde \[[@B32-biomedicines-08-00003],[@B33-biomedicines-08-00003],[@B37-biomedicines-08-00003],[@B48-biomedicines-08-00003]\], benzenepropanal \[[@B37-biomedicines-08-00003],[@B47-biomedicines-08-00003],[@B48-biomedicines-08-00003],[@B49-biomedicines-08-00003]\], and cinnamyl acetate/*trans*-cinnamyl acetate \[[@B2-biomedicines-08-00003],[@B29-biomedicines-08-00003],[@B36-biomedicines-08-00003]\]. The cinnamaldehyde/cinnamyl acetate type encompassed cinnamyl acetate, *trans*-cinnamaldehyde, and benzenepropanal \[[@B34-biomedicines-08-00003],[@B48-biomedicines-08-00003],[@B49-biomedicines-08-00003]\]. The cinnamyl acetate type included cinnamyl acetate \[[@B29-biomedicines-08-00003],[@B34-biomedicines-08-00003]\], 2-methylbenzofuran, and geranyl acetate \[[@B34-biomedicines-08-00003]\]. The linalool type contained linalool \[[@B3-biomedicines-08-00003],[@B29-biomedicines-08-00003],[@B34-biomedicines-08-00003],[@B48-biomedicines-08-00003]\] and cinnamaldehyde/*trans*-cinnamaldehyde \[[@B3-biomedicines-08-00003],[@B34-biomedicines-08-00003]\]. The camphor type contained camphor/D-(+)-camphor and L-bornyl acetate \[[@B29-biomedicines-08-00003],[@B34-biomedicines-08-00003],[@B36-biomedicines-08-00003],[@B48-biomedicines-08-00003]\] and limonene \[[@B34-biomedicines-08-00003],[@B48-biomedicines-08-00003]\]. The mixed type comprised spathulenol \[[@B24-biomedicines-08-00003]\], neral \[[@B32-biomedicines-08-00003],[@B33-biomedicines-08-00003]\], L-bornyl acetate/bornyl acetate \[[@B29-biomedicines-08-00003],[@B30-biomedicines-08-00003],[@B34-biomedicines-08-00003],[@B41-biomedicines-08-00003],[@B48-biomedicines-08-00003]\], 1,8-cineol \[[@B24-biomedicines-08-00003],[@B32-biomedicines-08-00003],[@B33-biomedicines-08-00003]\], T-cadinol, and α-cadinol \[[@B29-biomedicines-08-00003],[@B34-biomedicines-08-00003],[@B41-biomedicines-08-00003],[@B48-biomedicines-08-00003]\].

### 3.1.1. Anti-Inflammatory and Wound Repair Activities {#sec3dot1dot1-biomedicines-08-00003}

Numerous studies reported the anti-inflammatory effect of *C. osmophloeum* \[[@B24-biomedicines-08-00003],[@B25-biomedicines-08-00003],[@B26-biomedicines-08-00003],[@B28-biomedicines-08-00003],[@B29-biomedicines-08-00003],[@B30-biomedicines-08-00003],[@B40-biomedicines-08-00003]\] and they have been applied to the medical treatment of animal organs, such as endotoxin-induced intestinal injury \[[@B27-biomedicines-08-00003]\], pancreas protection \[[@B3-biomedicines-08-00003]\], and lipopolysaccharide/D-galactosamine (LPS/D-GaIN)-induced acute hepatitis \[[@B6-biomedicines-08-00003]\]. Some of these studies identified the specific constituents of *C. osmophloeum* that accounted for the anti-inflammatory effect \[[@B23-biomedicines-08-00003],[@B26-biomedicines-08-00003],[@B28-biomedicines-08-00003],[@B30-biomedicines-08-00003],[@B40-biomedicines-08-00003]\]. For example, Kaempferitin, a constituent of *C. osmophloeum*, was reported to be an anti-inflammatory that could down-regulate the extracellular LDL-R (Low-Density Lipoprotein-Receptor), followed by ameliorating subsequent chronic inflammation-related diabetes mellitus \[[@B26-biomedicines-08-00003]\]. Several constituents of *C. osmophloeum*, including trans-cinnamaldehyde, caryophyllene oxide, L-borneol, L-bornyl acetate, eugenol, β-caryophyllene, E-nerolidol, and cinnamyl, were demonstrated to be anti-inflammatory, which could suppress the synthesis of nitric oxide (NO) by LPS-stimulated macrophages through an identical mechanism \[[@B29-biomedicines-08-00003],[@B30-biomedicines-08-00003]\]. Cinnamaldehyde was verified as the major anti-inflammation constituent whose activities were derived from the in vitro synthesis of LPS-stimulated macrophages \[[@B23-biomedicines-08-00003]\].

Other constituents such as Kaempferol glycosides were associated with nitric oxide inhibitory activities \[[@B28-biomedicines-08-00003]\]. In certain studies, linalool extracted from *C. osmophloeum* exhibited a protective effect on the pancreas by ameliorating pancreatic levels of interleukin (IL)-1β and nitric oxide \[[@B3-biomedicines-08-00003]\], which play an important role in the prevention of LPS-induced inflammation in vivo \[[@B40-biomedicines-08-00003]\].

*C. osmophloeum* has been used as a tyrosinase suppressor, which exhibited a substantial effect on wound repair. This phenomenon occurred through the inhibition of tyrosinase activity and reduced melanin content. Lee et al. carried out an animal experiment and explored the role of *C. osmophloeum* in wound repair and as an anti-oxidative agent. They evaluated a wound size assay, which revealed a decrease in the wound area by day 5 \[[@B20-biomedicines-08-00003]\].

In light of the specific activities of the constituents of *C. osmophloeum*, it is noteworthy to mention that one specific and major constituent (flavanol glycosides) with outstanding properties was involved in inhibiting the production of NO and cytokines (TNF-a and IL-12), from LPS/IFNc-activated macrophages (inhibition of inflammatory activities) \[[@B25-biomedicines-08-00003]\]. An additional study revealed the in vitro inhibitory effect of IL-1â and IL-6 production resulting from the 21 constituents of *C. osmophloeum* (cell-mediated immune response) observed \[[@B24-biomedicines-08-00003]\]. Anti-inflammatory activity studies of *C. osmophloeum* have also been applied systemically in specific disease treatment \[[@B3-biomedicines-08-00003],[@B22-biomedicines-08-00003],[@B27-biomedicines-08-00003],[@B40-biomedicines-08-00003]\]. Numerous mechanisms of inhibiting inflammation, including the compositional contents, mechanisms, anatomical parts, and promising investigations, have also been reported elsewhere \[[@B22-biomedicines-08-00003],[@B23-biomedicines-08-00003],[@B24-biomedicines-08-00003],[@B25-biomedicines-08-00003],[@B26-biomedicines-08-00003],[@B28-biomedicines-08-00003],[@B40-biomedicines-08-00003],[@B45-biomedicines-08-00003]\].

### 3.1.2. Antimicrobial Activities {#sec3dot1dot2-biomedicines-08-00003}

The literature survey indicated that several pathogenic bacteria, including *Escherichia coli*, *Pseudomonas aeruginosa*, *Enterococcus faecalis*, *Staphylococcus aureus*, *Staphylococcus epidermidis*, methicillin-resistant *Staphylococcus aureus (MRSA)*, *Klebsiella pneumoniae*, *Salmonella* sp., *and Vibrio parahaemolyticus* have been used to investigate the antibacterial activity of *C. osmophloeum* \[[@B30-biomedicines-08-00003]\]. For constituents of C. *osmophloeum*, the order of antibacterial activities was in the following sequence: cinnamaldehyde \> cinnamic acid \> cinnamyl alcohol \> cinnamyl acetate. Cinnamaldehyde has been used as a bactericidal agent of *Legionella pneumophila* in vitro \[[@B31-biomedicines-08-00003]\]. Two investigations confirmed that *C. osmophloeum* possesses antibacterial activities in both Gram-negative and Gram-positive bacteria \[[@B31-biomedicines-08-00003],[@B32-biomedicines-08-00003]\]. Hence, further study should be carried out to examine animals infected by a specific group or both Gram-negative and Gram-positive bacteria.

*C. osmophloeum* also has antifungal properties in rot fungi, such as *Coriolus versicolor*, *Lenzites betulina*, *Pycnoporus coccineus*, *Trichaptum abietinum*, *Oligoporus lowe*, *Laetiporus sulphureus*, *Antrodia taxa*, *Fomitopsis pinicola*, and *Phaeolus schweinitzii* \[[@B33-biomedicines-08-00003],[@B34-biomedicines-08-00003]\].

### 3.1.3. Antioxidant Activities {#sec3dot1dot3-biomedicines-08-00003}

As one of the biomaterials commonly used for traditional medical therapy, *C. osmophloeum* has been reported to be antioxidative, and its properties encompassing other medical-biological effects have been assessed systematically and independently by researchers worldwide \[[@B18-biomedicines-08-00003],[@B20-biomedicines-08-00003],[@B35-biomedicines-08-00003],[@B36-biomedicines-08-00003],[@B37-biomedicines-08-00003],[@B41-biomedicines-08-00003]\].

For the analysis of anti-oxidant activities, both in vitro \[[@B18-biomedicines-08-00003],[@B20-biomedicines-08-00003],[@B35-biomedicines-08-00003],[@B37-biomedicines-08-00003],[@B41-biomedicines-08-00003]\] and in vivo \[[@B35-biomedicines-08-00003],[@B36-biomedicines-08-00003]\] investigations have been carried out. The investigations consisted of several studies: a 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity assay \[[@B18-biomedicines-08-00003],[@B20-biomedicines-08-00003],[@B35-biomedicines-08-00003]\], a superoxide radical scavenging assay (NBT Assay), reducing power, lipid peroxidation using mouse brain homogenates, the metal chelating ability, photochemiluminescence (PCL) \[[@B35-biomedicines-08-00003]\], and an oxidative stress resistance assay \[[@B36-biomedicines-08-00003]\]. Several constituents of *C. osmophloeum* comprising trans-cinnamaldehyde \[[@B36-biomedicines-08-00003]\], alloaromadendrene \[[@B41-biomedicines-08-00003]\], and kaempferol-7-O-rhamnoside \[[@B35-biomedicines-08-00003]\] were proven to possess antioxidant properties.

DPPH and NBT Assays reported the antioxidant activities of kaempferol-7-O-rhamnoside \[[@B35-biomedicines-08-00003]\]. The content had an excellent inhibitory effect on rat aldose reductase \[[@B51-biomedicines-08-00003]\]. The flavonoid glycoside was proven to be the key antioxidant in a *C. osmophloeum* twig ethanolic extract \[[@B35-biomedicines-08-00003]\]. These activities are associated with beneficial health effects. Therefore, *cinnamomum* has been widely used for its medicinal purpose and in nutritional food \[[@B52-biomedicines-08-00003]\].

### 3.1.4. Antidyslipidemic Activities {#sec3dot1dot4-biomedicines-08-00003}

The activity of *C. osmophloeum* in lowering the cholesterol level was investigated by Lin et al. They showed that both Kaempferol and kaempferitrin from *C. osmophloeum* have antidyslipidemic activity \[[@B38-biomedicines-08-00003]\]. Furthermore, the S-(þ)-linalool in *C. osmophloeum* was also reported to have hypolipidemic activity by inhibiting the accumulation of body fat through downregulating adipocyte differentiation \[[@B39-biomedicines-08-00003]\]. Two in vivo studies disclosed encouraging results demonstrating that S-(þ)-linalool was effective at cutting lipid accumulation. They also showed that low-density lipoprotein (LDL) was significantly decreased compared to high-density lipoprotein (HDL) \[[@B38-biomedicines-08-00003],[@B39-biomedicines-08-00003]\].

### 3.1.5. Anti-Hyperglycemic Activities {#sec3dot1dot5-biomedicines-08-00003}

Diabetes mellitus (DM) has become a serious medical problem. Numerous studies have been conducted by adapting natural materials as DM therapy. Among these bio-resource candidates, *C. osmophloeum* is one of the promising candidates. Proanthocyanidin and tannin from *C. osmophloeum* may possess anti-hyperglycemic activity \[[@B21-biomedicines-08-00003]\]. CoTE (*C. osmophloeum* twig extracts) showed protein tyrosine phosphatase 1B inhibitory (PTP1B) activity to improve the insulin or leptin resistance \[[@B18-biomedicines-08-00003]\]. Linalool, the constituent of the essential oil of *C. Osmophloeum*, might ameliorate the pancreatic values of thiobarbituric acid reactive substances. The activities of superoxide dismutase and glutathione reductase ameliorated pancreatic levels of IL-1β and NO in vivo in streptozotocin-diabetes mellitus (STZ-DM)) animals \[[@B3-biomedicines-08-00003]\]. It was reported that a higher degree of polymerization of proanthocyanidins correlates with the inhibitory activity of α-glucosidase and α-amylase \[[@B21-biomedicines-08-00003]\]. The studies explored leaves and twigs with different contents for decreasing the blood glucose level and treating diabetes mellitus. The results indicated that the leaves were more effective than the twigs, which contained less linalool. Moreover, in a practical sense, the leaves were much easier to preserve than twigs.

### 3.1.6. Effects on the Cardiovascular System {#sec3dot1dot6-biomedicines-08-00003}

Cinnamaldehyde was shown to be one of the protective ingredients for cerebral microvascular endothelial cells in mice induced by aortic banding (AB) by reducing IL-1β-induced cyclooxygenase-2 (COX-2) activity \[[@B53-biomedicines-08-00003]\]. In addition, the protective role of cinnamaldehyde in cardiac hypertrophy induced by AB was related to its regulatory effect on the ERK1/2 signaling pathway \[[@B7-biomedicines-08-00003]\]. The effect on the cardiovascular system was related to the anti-inflammatory mechanism \[[@B7-biomedicines-08-00003],[@B53-biomedicines-08-00003]\]. The authors introduced cinnamaldehyde as a major compound extracted from *C. osmophloeum* and it was bought from Sigma-Aldrich (USA). It was discussed that *Cinnamomum cassia* (*C. cassia*) would be a potential drug for cardiovascular disease \[[@B7-biomedicines-08-00003]\]. Unreliable cinnamon species (*C. cassia* or *C. osmophloeum*) used in the report would be a critical issue to clarify because the authors may have been inconsistent in discussing the species of cinnamon.

### 3.1.7. Effect on Renal Disease and Anti-Hyperuricemia {#sec3dot1dot7-biomedicines-08-00003}

It was reported that cinnamaldehyde in *C. osmophloeum* successfully inhibited the high glucose-induced hypertrophy of renal interstitial fibroblasts, as indicated by the decreased cell size; the falling cellular hypertrophy index; and the descending protein levels of collagen IV, fibronectin, and α-smooth muscle actin \[[@B4-biomedicines-08-00003]\]. In order to decrease the level of uricemia, several in vivo study reports confirmed the proposed mechanisms \[[@B2-biomedicines-08-00003],[@B5-biomedicines-08-00003]\]. The cinnamaldehyde type of *C. osmophloeum* leaf oil demonstrated anti-hyperuricemia effects through its xanthine oxidase inhibitory activity. Xanthine oxidase can catalyze the oxidation of hypoxanthine/xanthine to produce uric acid. Gout and hyperuricemia are caused by an excessive accumulation of uric acid \[[@B2-biomedicines-08-00003],[@B19-biomedicines-08-00003]\].

### 3.1.8. Anti-Tumor and Anti-Cancer Activity {#sec3dot1dot8-biomedicines-08-00003}

Trans-cinnamaldehyde, a bioactive content of *C. osmophloeum*, showed an inhibition of tumor growth \[[@B46-biomedicines-08-00003],[@B54-biomedicines-08-00003],[@B55-biomedicines-08-00003]\]. It could stimulate Ca^2+^ entry with subsequent cell membrane scrambling and cell shrinkage, hallmarks of eryptosis, and the suicidal death of erythrocytes \[[@B46-biomedicines-08-00003]\]. Trans-cinnamaldehyde exposure induced cell death via caspase-dependent and -independent pathways resulting from the depletion or induction of ROS \[[@B54-biomedicines-08-00003]\]. Lignan ester, one of the *C. osmophloeum* constituents, was shown to be a possible anticancer compound (liver and oral cancer). The cytotoxicity had a significant effect on human liver cancer (HepG2 and Hep3B) and oral cancer (Ca9-22) cells \[[@B42-biomedicines-08-00003]\].

3.2. Potential Use of C. osmophloeum for the Treatment of Oral Mucositis (OM) {#sec3dot2-biomedicines-08-00003}
-----------------------------------------------------------------------------

The current protocols of medicine for chemotherapy are associated with oral mucositis. Cytarabine, high-dose 5-fluororacil, alkylating agents, and platinum-based compounds are highly associated with the incidence of oral mucositis. Actinomycin D, amsacrin, bleomycin, busulfan, capecitabine, carboplatin, chlorambucil, cisplatin, cytarabine, docetaxel, doxorubicin, etoposide, floxuridine, ifofsamide, irinotecan, leucovorin, methotrexate, mitoxantron, oxaliplatin, paclitaxel, plicamycin, tioguanin, vinblastine, vincristine, vindecine, and vinorelbine (the protocol can be combined) are the medicines used for chemotherapy and are reported to lead to the development of oral mucositis \[[@B56-biomedicines-08-00003],[@B57-biomedicines-08-00003]\]. In order to prevent oral mucositis, the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Oral Oncology (ISOO) help clinics by comprising Clinical Practice Guidelines for Oral Mucositis \[[@B58-biomedicines-08-00003]\]. The recommendations are comprised of basic oral care, growth factors and cytokines, anti-inflammatory agents, laser and other light therapy, cryotherapy, and natural and miscellaneous agents ([Table 3](#biomedicines-08-00003-t003){ref-type="table"}). Köstler et al. provided several experimental approaches to treat oral mucositis; they included locally applied non-pharmacological methods, anti-inflammatory and mucosa protectant agents, cytokines, granulocyte colony-stimulating factor (G-CSF, filgrastim) and granulocyte-macrophage colony-stimulating factor (GM-CSF, molgramostim), antiseptic agents, corticosteroids, mouth-coating agents, and dexpanthenol \[[@B57-biomedicines-08-00003]\].

The study of *C. osmophloeum* and/or its constituents in OM are limited. In one study, the effect of cinnamaldehyde on oral mucositis and an evaluation of the salivary total antioxidant capacity of gamma-irradiated rats were carried out. The saliva samples were taken from the rats in triplicate \[[@B59-biomedicines-08-00003]\]. In order to evaluate the consequences and severity of mucositis, the conditions of the oral cavity were assessed by using Parkin's clinical scale, where 0 represents normal mucosa, 0.5 indicates normally pink mucosa, 1 stands for minor red mucosa, 2 is severe red mucosa, 3 is local desquamation, 4 describes exudation and crust around less than half of the lip area, and 5 characterizes exudation and crust for more than half of the lip area \[[@B60-biomedicines-08-00003]\]. The authors concluded that the clinical effects in the intervention group seemed to be due to the antioxidant, antibacterial, and anti-inflammatory effects of cinnamaldehyde. It is noteworthy to mention that through anti-inflammation and antioxidant mechanisms, cinnamaldehyde would delay the onset of oral mucositis. Moreover, alteration in the oral microflora of existing bacteria in the fourth phase (ulceration phase) could exacerbate the severity of mucositis, whereas cinnamaldehyde alleviated oral mucositis via its antibacterial properties \[[@B59-biomedicines-08-00003]\]. A recent investigation reported the effect of cinnamon bark fractions (an essential oil and an aqueous extract) on *Candida albicans* growth inhibition (growth, biofilm formation, and adherence properties) and oral epithelial cells (barrier integrity and inflammatory response) \[[@B61-biomedicines-08-00003]\]. The anti-adherence and anti-inflammatory properties of proanthocyanidins, a family of polyphenols containing flavan-3-ol oligomers and polymers, are used to treat oral infections \[[@B61-biomedicines-08-00003],[@B62-biomedicines-08-00003]\]. The two pro-inflammatory cytokines, IL-6 and IL-8, which serve as important cytokines in the development of oral mucositis, were reduced by an aqueous extract enriched with proanthocyanidins of the cinnamon fraction. This shows that the cinnamon presented in the study may be a promising agent in the alleviation of oral mucositis \[[@B61-biomedicines-08-00003]\].

Other biomaterials or herbal products, such as *Aloe vera*, *Acacia catechu*, Chamomile, Hangeshashinto, indigowood root (*Isatis indigotica Fort.*), honey, *Traumeel S*, water grass decoction, and *Weleda Ratanhia*, also showed similar effects on the alleviation of OM via anti-inflammation activities \[[@B17-biomedicines-08-00003],[@B63-biomedicines-08-00003],[@B64-biomedicines-08-00003],[@B65-biomedicines-08-00003],[@B66-biomedicines-08-00003],[@B67-biomedicines-08-00003],[@B68-biomedicines-08-00003],[@B69-biomedicines-08-00003],[@B70-biomedicines-08-00003],[@B71-biomedicines-08-00003],[@B72-biomedicines-08-00003]\]. The bioactive properties of the yarrow plant (*Achillea mileofolium*), honey, *Callendula officinalis* flowers, *Hipophae rhamnoides L.* plant, Chamomile, and *Aloe vera* were associated with antioxidant, anti-inflammatory, antibacterial, and wound healing effects of oral mucositis therapy ([Table 4](#biomedicines-08-00003-t004){ref-type="table"}) \[[@B64-biomedicines-08-00003],[@B65-biomedicines-08-00003],[@B66-biomedicines-08-00003],[@B72-biomedicines-08-00003],[@B73-biomedicines-08-00003],[@B74-biomedicines-08-00003],[@B75-biomedicines-08-00003],[@B76-biomedicines-08-00003],[@B77-biomedicines-08-00003]\]. Similar to the advantages of the medical-biological activities of these herbal agents, *C. osmophloeum* would provide an identical mechanism for relieving oral mucositis.

According to antibacterial mechanisms, several studies demonstrated bacterial changes due to radiotherapy and/or chemotherapy \[[@B85-biomedicines-08-00003]\]. The bacteria were *Gemella haemolysans*, *Streptococcus mitis* \[[@B86-biomedicines-08-00003]\], *Escherichia coli*, *Pseudomonas aeruginosa*, *Enterobacter* sp., *Klebsiella pneumonia* \[[@B87-biomedicines-08-00003]\], *Staphylococcus aureus*, *Staphylococcus epidermidis*, *Parvimonasmicra*, *Fusobacterium nucleatum*, *Treponema denticola*, *C. glabrata*, *C. kefyr* \[[@B88-biomedicines-08-00003]\], and *Porphyromonas gingivalis* \[[@B89-biomedicines-08-00003]\]. Among these bacteria, *C. osmophloeum* has been confirmed to possess the antibacterial properties of *Pseudomonas aeruginosa*, *Staphylococcus aureus*, and *Staphylococcus epidermidis* ([Figure 3](#biomedicines-08-00003-f003){ref-type="fig"}) \[[@B32-biomedicines-08-00003]\].

Flavanoid-rich fractions containing kaempferitin in *Bauhinia forficata* leaves have been investigated and shown to be effective ingredients for preventing the intestinal toxic effects of irinotecan chemotherapy. It was stated that kaempferitin, as one of the major active contents of *C. osmophloeum*, has been tested to prevent or reduce the severity of intestinal mucositis \[[@B26-biomedicines-08-00003],[@B90-biomedicines-08-00003]\]. The chemotherapy drug 5-Fluororacil possesses side effects (i.e., induces mucositis manifestations in oral and gastrointestinal after chemotherapy). *Chimonatus Nitens var. salicifolius* aqueous extract contains three flavonoid contents: quercetin, kaempferol, and rutin, which might have an anti-inflammatory effect on gastrointestinal mucositis \[[@B91-biomedicines-08-00003]\]. Kaempferol, cinamic acid, and nine other constituents obtained in mucoadhesive propolis agent have been proven to be effective in reducing radiation-induced oral mucositis. A clinical study of 24 patients revealed that mucositis only developed in two patients and each developed grade 1 mucositis and grade 2 mucositis, respectively; however, in the remaining 20 patients, mucositis did not develop \[[@B92-biomedicines-08-00003]\].

Previous studies investigated the potential of *C. osmophloeum* to reduce oral mucositis. Nonetheless, *C. osmopohloeum*, which is a species of cinnamon, faces challenges in its use as an oral treatment. In addition, this review has several limitations. First, there are limited data on the medical-biological effects of *C. osmophloeum* and its potential use in oral mucositis therapy. Secondly, the reported events related to oral stomatitis allergy induced by cinnamon should be a concern \[[@B93-biomedicines-08-00003],[@B94-biomedicines-08-00003],[@B95-biomedicines-08-00003]\]. In summary, *C. osmophloeum* and its constituent are anticipated to be effective and efficient in reducing the severity of OM by preventing secondary bacterial infection through their bactericidal activity, preventing the development of the second phase of OM (the primary damage response) or interrupting the third phase in which pro-inflammatory cytokines could enhance and accelerate the process of wound healing ([Figure 4](#biomedicines-08-00003-f004){ref-type="fig"}).

4. Conclusions {#sec4-biomedicines-08-00003}
==============

In conclusion, in vitro and animal studies have revealed the various medical-biological activities of *C. osmophloeum* encompassing anti-inflammatory, antibacterial, antioxidant, anti-tumor and anti-cancer, anti-hyperglycemic, anti-hyperuricemia, and antidyslipidemic activities and the effect on the cardiovascular system that have been used for renal disease therapy. Various chemical contents identified in *C. osmophloeum* contribute to its valuable medical bioactivities. Several medical-biological activities are attributed to the active ingredients of *C. osmophloeum* for OM therapy. The key to OM alleviation could be the anti-inflammatory effect of *C. osmophloeum*, as the activation of several transcription factors might release the inflammatory reaction in the second phase of OM. The antibacterial and antioxidant properties of CO might also alleviate OM. These effects might occur during the first phase of OM, preventing the generation of reactive oxygen species, or in the fourth phase, inhibiting colonized bacteria. It was suggested that bacterial cell wall products could be prevented from entering the oral submucosa.
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![The systematic search for medical-biological activities of *Cinnamomum osmophloeum*.](biomedicines-08-00003-g001){#biomedicines-08-00003-f001}

![Chemical structures of *Cinnamomum osmophloeum* chemotypes: (**a**) cinnamaldehyde, (**b**) cinnamyl acetate, (**c**) linalool, and (**d**) camphor.](biomedicines-08-00003-g002){#biomedicines-08-00003-f002}

![Antibacterial properties of *C. osmophloeum* (**A**) and bacterial infection of oral mucositis (**B**).](biomedicines-08-00003-g003){#biomedicines-08-00003-f003}

![Proposed potential use of *C. osmophloeum* in the alleviation of oral mucositis (OM)**.** *C. osmophloeum* ameliorated oxidative stress and pro-inflammation through its constituents. Several studies have investigated the anti-inflammation, antibacterial, and antioxidant activities. The review of medical-biological activities showed that *C. osmophloeum* and its constituents inhibit the pro-inflammatory response. *C. osmophloeum* potentially prevents the second phase of oral mucositis (the primary damage response) or may intercept in the third phase, with pro-inflammatory cytokines providing a positive reaction to enhance and accelerate the process of wound healing. *C. osmophloeum* was also confirmed to be bactericidal and inhibit bacteria which can reduce the severity of oral mucositis or secondary bacterial infection.](biomedicines-08-00003-g004){#biomedicines-08-00003-f004}

biomedicines-08-00003-t001_Table 1

###### 

Beneficial biological activities of *C. osmophloeum.*

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Bioactivity                                                   Chemical Identification                *C. osmophloeum* Parts                                                                                                        Constituent (s)                                                   Study                                                                                                     Mechanisms                                                                                                                                                                                                   Reference
  ------------------------------------------------------------- -------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------
  Anti-inflammatory effect                                      LC-MS/MS                               Leaves                                                                                                                        Kaempferitrin                                                     In vitro                                                                                                  Down-regulate the extracellular LDL-R (chronic inflammation-related diabetes mellitus)                                                                                                                       Ku et al., (2017) \[[@B26-biomedicines-08-00003]\]

  GC-MS                                                         Twigs                                  Trans-cinnamaldehyde, caryophyllene oxide, L-borneol, L-bornyl acetate, eugenol, β-caryophyllene, E-nerolidol, and cinnamyl   In vitro                                                          Suppressing nitric oxide synthesis by LPS-stimulated macrophages                                          Tung et al. (2008) \[[@B30-biomedicines-08-00003]\]                                                                                                                                                          

  GC-MS                                                         Leaves                                 Trans-cinnamaldehyde,(-)-aromadendrene,\                                                                                      In vitro                                                          Suppressing nitric oxide production by LPS-stimulated macrophages                                         Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]                                                                                                                                                          
                                                                                                       caryophyllene oxide,\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                       T-cadinol, and α-cadinol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  GC-MS and HPLC                                                Leaves                                 Cinnamaldehyde                                                                                                                In vitro                                                          Cinnamaldehyde inhibits LPS-mediated pro-inflammatory cytokine production                                 Chao et al. (2008) \[[@B23-biomedicines-08-00003]\]                                                                                                                                                          

  TLC                                                           Leaves                                 NA                                                                                                                            In vitro                                                          Inhibition of the production of NO and cytokines (TNF-a and IL-12), from LPS/IFNc-activated macrophages   Fang, Rao & Tzeng (2005) \[[@B25-biomedicines-08-00003]\]                                                                                                                                                    

  CC, HPLC, TLC, ESIMS, and GC-MS                               Twigs                                  Kaempferol glycosides                                                                                                         In vitro                                                          Nitric oxide production inhibitory activities                                                             Lin & Chang(2012) \[[@B28-biomedicines-08-00003]\]                                                                                                                                                           

  GC-MS                                                         Leaves                                 Linalool and cinnamaldehyde                                                                                                   In vivo                                                           Inhibition of the expression of molecules in both TLR4 and NLRP3 signaling pathways                       Lee et al. (2018) \[[@B40-biomedicines-08-00003]\]                                                                                                                                                           

  GC-MS                                                         Leaves                                 21 compounds were identified                                                                                                  In vitro                                                          Inhibition of IL-1â and IL-6 production                                                                   Chao et al. (2005) \[[@B24-biomedicines-08-00003]\]                                                                                                                                                          

  Antibacterial activity                                        GC                                     Leaves                                                                                                                        Cinnamaldehyde                                                    In vitro                                                                                                  Bactericidal                                                                                                                                                                                                 Chang, Chen & Chang (2001) \[[@B32-biomedicines-08-00003]\]

  GC-MS                                                         Leaves                                 Cinnamaldehyde, cinnamic acid, cinnamyl alcohol, and cinnamyl acetate                                                         In vitro                                                          Bacterial inhibition                                                                                      Chang et al. (2008) \[[@B31-biomedicines-08-00003]\]                                                                                                                                                         

  Antifungal activity                                           GC-MS                                  Leaves                                                                                                                        Cinnamaldehyde                                                    In vitro                                                                                                  NA                                                                                                                                                                                                           Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  GC-MS                                                         Leaves                                 Cinnamaldehyde                                                                                                                In vitro                                                          NA                                                                                                        Wang, Chen & Chang (2005) \[[@B33-biomedicines-08-00003]\]                                                                                                                                                   

  Antioxidant activities                                        ESIMS                                  Twigs                                                                                                                         Kaempferol-7-O-rhamnoside                                         In vitro                                                                                                  NA                                                                                                                                                                                                           Chua, Tung, & Chang (2008) \[[@B35-biomedicines-08-00003]\]

                                                                GC-MS and\                             Leaves                                                                                                                        Alloaromadendrene                                                 In vitro                                                                                                  NA                                                                                                                                                                                                           Yu et al. (2014) \[[@B41-biomedicines-08-00003]\]
                                                                GC−FID                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                GC-MS and GC-FID                       Leaves                                                                                                                        Trans-cinnamaldehyde                                              In vitro                                                                                                  NA                                                                                                                                                                                                           Yeh et al. (2013) \[[@B37-biomedicines-08-00003]\]

                                                                GC-MS and GC-FID                       Leaves                                                                                                                        Trans cinnamaldehyde                                              In vivo                                                                                                   Expression of antioxidative-related genes was pointedly affected by essential oils from *C. osmophloeum*.                                                                                                    Hsu et al. (2012) \[[@B36-biomedicines-08-00003]\]

  Antidyslipidemic activity                                     HPLC                                   Leaves                                                                                                                        Kaempferol and kaempferitrin                                      In vivo                                                                                                   Cholesterol-lowering activity                                                                                                                                                                                Lin et al. (2011) \[[@B38-biomedicines-08-00003]\]

  Anti-hyperglycemic and antioxidant activities                 A modified vanillin-H~2~SO~4~ assay\   Twigs                                                                                                                         Proanthocyanidin and tannin contents                              In vitro                                                                                                  CoTE has PTP1B inhibitory activity to improve insulin or leptin resistance                                                                                                                                   Lin et al. (2016) \[[@B18-biomedicines-08-00003]\]
                                                                A modified acid-butanol assay\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                The AlCl~3~ method                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Hepatoprotective effects                                      NA                                     Leaves                                                                                                                        trans-cinnamaldehyde, ()-aromadendrene, T-cadinol, or R-cadinol   In vivo                                                                                                   The modulation of anti-inflammatory activities (decreased the aspartate aminotransferase (AST), alanine aminotransferase (ALT), tumor necrosis factor-R (TNF-R), and interleukin 6 (IL-6) levels in serum)   Tung et al. (2011) \[[@B6-biomedicines-08-00003]\]

  Pancreas Protective Effect and Hypoglycemic activity          GC/MS                                  Leaves                                                                                                                        Linalool                                                          In vivo                                                                                                   1\. Decreased pancreatic values of thiobarbituric acid reactive substances and activities of superoxide dismutase and glutathione reductase\                                                                 Lee et al. (2013) \[[@B3-biomedicines-08-00003]\]
                                                                                                                                                                                                                                                                                                                                                                                                                 2. Decreased pancreatic levels of interleukin-1β and nitric oxide                                                                                                                                            

  Prevent Cardiac Hypertrophy                                   HPLC                                   Leaves                                                                                                                        Cinnamaldehyde                                                    In vivo                                                                                                   The protective role of cinnamaldehyde related to the ERK1/2 signaling pathway.                                                                                                                               Yang et al. (2015) \[[@B7-biomedicines-08-00003]\]

  Treatment of renal interstitial fibroblasts                   NA                                     Leaves                                                                                                                        Cinnamaldehyde                                                    In vitro                                                                                                  Inhibit high glucose-induced hypertrophy (decreased cell size; cellular hypertrophy index; and protein levels of collagen IV, fibronectin, and α-smooth muscle actin).                                       Chao et al. (2010) \[[@B4-biomedicines-08-00003]\]

  Anticancer (liver and oral cancer)                            TLC, CC and HPLC                       Heart wood and roots                                                                                                          Lignan Esters                                                     In vitro                                                                                                  Tumor cell growth inhibition                                                                                                                                                                                 Chen et al. (2010) \[[@B42-biomedicines-08-00003]\]

  Anti-diabetes                                                 TLC                                    Twigs                                                                                                                         Kaempferol glycosides CO-1 and CO-2                               In vitro                                                                                                  Enhanced adiponectin secretion, and activation of the insulin signaling pathway                                                                                                                              Lee et al. (2009) \[[@B43-biomedicines-08-00003]\]

  Anti-hyperuricemia effect                                     GC-MS                                  Leaves                                                                                                                        Cinnamaldehyde                                                    In vivo                                                                                                   Acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels                                                                                                                                  Wang et al. (2008) \[[@B2-biomedicines-08-00003]\]

  Anxiolytic properties                                         HPLC                                   Leaves                                                                                                                        Linalool                                                          In vivo                                                                                                   Reduced the amount of 5-HT, DA and NE and increased the level of dopamine in striatum                                                                                                                        Cheng et al. (2014) \[[@B44-biomedicines-08-00003]\]

  Wound Repair Promoter and Antioxidant                         NA                                     Leaves                                                                                                                        NA                                                                In vitro and in vivo                                                                                      Inhibited tyrosinase activity and reduced melanin content                                                                                                                                                    Lee et al. (2015) \[[@B20-biomedicines-08-00003]\]

  Anti-inflammatory and anti-cancer properties                  NA                                     Barks                                                                                                                         NA                                                                In vivo                                                                                                   The growth inhibition of NO, TNF-, and IL-12, and tumor cell proliferation                                                                                                                                   Rao et al. (2007) \[[@B22-biomedicines-08-00003]\]

  Hypolipidemic effects                                         NA                                     Leaves                                                                                                                        S-(þ)-linalool                                                    In vivo                                                                                                   Inhibited lipid accumulation through downregulation of 3T3-L1 adipocyte differentiation                                                                                                                      Cheng et al. (2018) \[[@B39-biomedicines-08-00003]\]

  Effect on the human immune system                             HS-GC/MS and HPLC                      Leaves                                                                                                                        Cinnamaldehyde                                                    In vivo                                                                                                   Cytokines modulatory effect                                                                                                                                                                                  Lin et al. (2011) \[[@B45-biomedicines-08-00003]\]

  Potential skin-whitening and protective agent                 NA                                     Leaves                                                                                                                        Cinnamaldehyde and cinnamylacetate                                In vitro                                                                                                  Neutralized the IBMX-induced increase in melanin content in B16-F10 cells by inhibiting tyrosinase gene expression at the level of transcription                                                             Lee et al. (2015) \[[@B20-biomedicines-08-00003]\]

  Anti-inflammatory effect in intestine                         GC/MS                                  Leaves                                                                                                                        Linalool                                                          In vivo                                                                                                   The suppression of the TLR4 pathway by CO and partly by the inhibitory effect of CO on the activity of xanthine oxidase                                                                                      Lee et al. (2015) \[[@B27-biomedicines-08-00003]\]

  Anti-tumor                                                    NA                                     Leaves                                                                                                                        Trans-cinnamaldehyde                                              In vitro                                                                                                  Trans-cinnamaldehyde triggers suicidal death oferythrocytes, i.e., cells devoid of mitochondria and gene expression.                                                                                         Theurer et al. (2013) \[[@B46-biomedicines-08-00003]\]

  Dietary supplements and treatment of hyperuricemia and gout   GC-MS and GC-FID                       Leaves                                                                                                                        Cinnamaldehyde                                                    In vitro                                                                                                  The xanthine oxidase inhibitory activity                                                                                                                                                                     Huang et al. (2018) \[[@B19-biomedicines-08-00003]\]

  Anti-hyperglycemic and antioxidant activities                 (MALDI/MS) (RP-HPLC) /MS/MS            Twigs                                                                                                                         Proanthocyanidin                                                  In vitro                                                                                                  The proanthocyanidins in CoTE mainly consisted of (epi)catechin and contained at least one A-type linkage. The inhibitory activity of α-glucosidase and α-amylase                                            Lin et al. (2016) \[[@B21-biomedicines-08-00003]\]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: Not available; LC: liquid chromatography; MS: mass spectrometry; GC: gas chromatography; HPLC: high-performance liquid chromatography; TLC: thin layer chromatography; CC: column chromatography; ESIMS: electrospray ionization mass spectrometry; GC-FID: gas chromatography−flame ionization detection; MALDI: matrix-assisted laser desorption/ionization; RP: reverse phase.

biomedicines-08-00003-t002_Table 2

###### 

Chemotypes and chemical compositions of *C. osmophloeum*. All of the studies on *C. osmophloeum* chemical contents utilized leaf extracts, except number 48 (twig extract).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No                                         Chemical Compositions                                                References
  ------------------------------------------ -------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------
  **Cinnamaldehyde type**                                                                                         

  1                                          Cinnamaldehyde, Geranyl acetate, Benzaldehyde.                       Chang et al. (2001), Wang et al. (2005) \[[@B32-biomedicines-08-00003],[@B33-biomedicines-08-00003]\]

  2                                          *trans*-Cinnamaldehyde, Benzenepropanal, 4-Allylanisole.             Chang et al. (2008) \[[@B31-biomedicines-08-00003]\]

  3                                          *trans*-Cinnamaldehyde, Cinnamyl acetate,\                           Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]
                                             3-Phenylpropionaldehyde.                                             

  4                                          *trans*-Cinnamaldehyde, Cinnamyl acetate,\                           Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]
                                             3-Phenylpropionaldehyde.                                             

  5                                          *trans*-Cinnamaldehyde, Cinnamyl acetate,\                           Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]
                                             3-Phenylpropionaldehyde.                                             

  6                                          *trans*-Cinnamaldehyde, Cinnamyl acetate, 3-Pheaylpionaldehyde.      Wang et al. (2008) \[[@B2-biomedicines-08-00003]\]

  7                                          *trans*-Cinnamaldehyde, *trans*-Cinnamyl acetate,\                   Hsu et al. (2012) \[[@B36-biomedicines-08-00003]\]
                                             3-Phenylpropionaldehyde.                                             

  8                                          *trans*-Cinnamaldehyde, Benzenepropanal, Benzaldehyde.               Yeh et al. (2013), Cheng (2008) \[[@B37-biomedicines-08-00003],[@B49-biomedicines-08-00003]\]

  9                                          *trans*-Cinnamaldehyde, Benzaldehyde, Benzenepropanal.               Yeh et al. (2013) \[[@B37-biomedicines-08-00003]\]

  10                                         *trans*-Cinnamaldehyde, Benzaldehyde, Benzenepropanal.               Yeh et al. (2013) \[[@B37-biomedicines-08-00003]\]

  11                                         *trans*-Cinnamaldehyde, Benzaldehyde, Benzenepropanal.               Yeh et al. (2013) \[[@B37-biomedicines-08-00003]\]

  12                                         *trans*-Cinnamaldehyde, Linalool, *trans*-Cinnamyl acetate.          Yeh et al. (2013) \[[@B37-biomedicines-08-00003]\]

  13                                         *trans*-Cinnamaldehyde, Benzaldehyde,\                               Huang et al. (2018) \[[@B19-biomedicines-08-00003]\]
                                             3-Phenylpropionaldehyde.                                             

  14                                         *trans*-Cinnamaldehyde, *trans*-Cinnamyl acetate, Benzenepropanal.   Mdoe et al. (2014) \[[@B47-biomedicines-08-00003]\]

  15                                         Cinnamaldehyde, Geranyl acetate, Benzaldehyde.                       Wang et al. (2005) \[[@B33-biomedicines-08-00003]\]

  16                                         *trans*-Cinnamaldehyde, Cinnamyl acetate, β-Caryophyllene.           Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  17                                         *trans*-Cinnamaldehyde, Benzenepropanal, benzaldehyde.               Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  18                                         *trans*-Cinnamaldehyde, Benzenepropanal, benzaldehyde.               Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  19                                         *trans*-Cinnamaldehyde, Benzenepropanal,\                            Cheng et al. (2009) \[[@B50-biomedicines-08-00003]\]
                                             4-Allylanisole.                                                      

  20                                         *trans*-Cinnamaldehyde, Cinnamyl acetate, Bornyl acetate.            Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  21                                         *trans*-Cinnamaldehyde, Benzenepropanal, Eugenol.                    Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  22                                         *trans*-Cinnamaldehyde, Benzenepropanal, Cinnamyl acetate.           Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  **Cinnamaldehyde/Cinnamyl acetate type**                                                                        

  23                                         Cinnamyl acetate, *trans*-Cinnamaldehyde, Benzenepropanal.           Chang et al. (2008) \[[@B31-biomedicines-08-00003]\]

  24                                         *trans*-Cinnamaldehyde, Cinnamyl acetate, Benzenepropanal.           Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  25                                         Cinnamyl acetate, *trans*-Cinnamaldehyde, Camphene.                  Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  26                                         Cinnamyl acetate, *trans*-Cinnamaldehyde, Benzenepropanal.           Cheng et al. (2009) \[[@B50-biomedicines-08-00003]\]

  27                                         *trans*-Cinnamaldehyde, Cinnamyl acetate, Benzenepropanal.           Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  28                                         Cinnamyl acetate, *trans*-Cinnamaldehyde, Camphene.                  Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  **Cinnamyl acetate type**                                                                                       

  29                                         Cinnamyl acetate, 2-Methylbenzofuran, Geranyl acetate.               Chang et al. (2008) \[[@B31-biomedicines-08-00003]\]

  30                                         Cinnamyl acetate, *trans*-Cinnamaldehyde, Caryophyllene oxide.       Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]

  31                                         Cinnamyl acetate, 2-Methylbenzofuran, Geranyl acetate.               Cheng et al. (2009) \[[@B50-biomedicines-08-00003]\]

  32                                         Cinnamyl acetate, 2-Methylbenzofuran, Geranyl acetate.               Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  **Linalool type**                                                                                               

  33                                         Linalool, *trans*-Cinnamaldehyde, Cinnamyl acetate.                  Chang et al. (2008) \[[@B31-biomedicines-08-00003]\]

  34                                         Linalool, β-Caryophyllene, 4-Allylanisole.                           Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]

  35                                         Linalool, Cinnamaldehyde, 3-phenyl-2-propenal.                       Lee et al. (2013) \[[@B3-biomedicines-08-00003]\]

  36                                         Linalool, Citral, Coumarin.                                          Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  37                                         Linalool, *trans*-Cinnamaldehyde,\                                   Cheng et al. (2009) \[[@B50-biomedicines-08-00003]\]
                                             4-Allylanisole.                                                      

  38                                         Linalool, Coumarin, *trans*-Cinnamaldehyde.                          Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  **Camphor type**                                                                                                

  39                                         Camphor, L-Bornyl acetate, (+)-Limonene.                             Chang et al. (2008) \[[@B31-biomedicines-08-00003]\]

  40                                         D-(+)-Camphor, L-Bornyl acetate, α-Terpineol                         Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]

  41                                         D-(+)-Camphor, L-Bornyl acetate, α-Terpineol.                        Hsu et al. (2012) \[[@B36-biomedicines-08-00003]\]

  42                                         Camphor, bornyl acetate, Limonene.                                   Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  43                                         Camphor, L-Bornyl acetate, (+)-Limonene.                             Cheng et al. (2009) \[[@B50-biomedicines-08-00003]\]

  44                                         Camphor, Bornyl acetate, Limonene.                                   Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]

  **Mixed type**                                                                                                  

  45                                         Spathulenol, Linalool, α-Terpineol.                                  Chang et al. (2008) \[[@B31-biomedicines-08-00003]\]

  46                                         Neral, 1.8-Cineol, Linalool.                                         Chang et al. (2001), Wang et al. (2005) \[[@B32-biomedicines-08-00003],[@B33-biomedicines-08-00003]\]

  47                                         L-Bornyl acetate, Caryophyllene oxide, γ-Eudesmol.                   Tung et al. (2008) \[[@B30-biomedicines-08-00003]\]

  48                                         L-Bornyl acetate, α-Cadinol, T-Cadinol.                              Tung et al. (2010) \[[@B29-biomedicines-08-00003]\]

  49                                         L-bornyl acetate, T-Cadinol, α -Cadinol.                             Yu et al. (2014) \[[@B41-biomedicines-08-00003]\]

  50                                         1,8-cineole, spathulenol, santolina triene.                          Chao et al. (2005) \[[@B24-biomedicines-08-00003]\]

  51                                         T-Cadinol, α -Cadinol., bornyl acetate.                              Cheng et al. (2004) \[[@B48-biomedicines-08-00003]\]

  52                                         Geranial, Neral, 1,8-Cineole.                                        Cheng et al. (2009) \[[@B50-biomedicines-08-00003]\]

  53                                         T-Cadinol, α -Cadinol, bornyl acetate.                               Cheng et al. (2006) \[[@B34-biomedicines-08-00003]\]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

biomedicines-08-00003-t003_Table 3

###### 

Interventions to prevent oral mucositis (clinical practice guidelines) proposed by the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Oral Oncology (ISOO).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Intervention                       Protocol                                                             Population                                                                                                                                              Evidence of Effectiveness
  ---------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------
  Basic oral care                    Tooth brushing, flossing, and one mouth rinse                        All age groups and across all cancer treatment modalities                                                                                               Not strong evidence

  Growth factors and cytokines       Palifermin (keratinocyte\                                            Patients receiving high-dose chemotherapy and total body irradiation, followed by autologous stem cell transplantation for hematological malignancies   Strong evidence
                                     growth factor-1)                                                                                                                                                                                                             

  Anti-inflammatory agents           Benzydamine mouthwash                                                Patients with head and neck cancer receiving moderate-dose radiation therapy (up to 50 Grays), without concomitant chemotherapy                         Strong evidence

  Laser and other light therapy      Low-level laser therapy (LLLT)                                       Patients receiving\                                                                                                                                     Strong evidence
                                                                                                          high-dose chemotherapy for HSCT with or without\                                                                                                        
                                                                                                          total body irradiation                                                                                                                                  

  Cryotherapy                        The placement\                                                       Patients receiving bolus\                                                                                                                               Strong evidence
                                     of ice chips in the mouth                                            dosing of 5-fluorouracil                                                                                                                                

  Natural and miscellaneous agents   Systemic zinc supplements administered orally (antioxidant effect)   Patients with oral cancer undergoing radiotherapy or chemoradiation                                                                                     Not strong evidence
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

biomedicines-08-00003-t004_Table 4

###### 

Bioactive properties of natural agents for oral mucositis therapy.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Natural Agents                                                                                                                                                              Bioactivity                                                                                        References
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- --------------------------------------------------------------
  Yarrow Plant (*Achillea millefolium*)                                                                                                                                       Anti-bacterial and anti-inflammatory effect                                                        Mirazandeh et al. (2014) \[[@B73-biomedicines-08-00003]\]

  Manuka Honey (*Leptospermum scoparium*)                                                                                                                                     Wound healing and anti-microbial                                                                   Hawley et al. (2013) \[[@B72-biomedicines-08-00003]\]

  Weleda Pflanzen-Zahngel and Weleda Ratanhia-Mundwasser                                                                                                                      Anti-inflammatory,\                                                                                Tiemann et al. (2007) \[[@B70-biomedicines-08-00003]\]
                                                                                                                                                                              anti-bacterial, and lesion healing                                                                 

  *Calendula officinalis* flowers                                                                                                                                             Anti-inflammatory, anti-bacterial, and anti-oxidant                                                Babaee et al. (2013) \[[@B74-biomedicines-08-00003]\]

  Honey and coffee                                                                                                                                                            Antioxidant, anti-microbial,\                                                                      Raeessi et al. (2014) \[[@B63-biomedicines-08-00003]\]
                                                                                                                                                                              and anti-inflammatory                                                                              

  *Aloe vera*                                                                                                                                                                 Anti-inflammatory, bactericidal, and wound healing                                                 Sahebjamee et al. (2015) \[[@B71-biomedicines-08-00003]\]

  Hangeshashinto: *Pinelliae tuber*, *Scutellariae Radix*, *Glycyrrhizae Radix*, *Zizyphi Fructus*, *Ginseng Radix*, *Zingiberis Processum rhizoma*, *and Coptidis rhizome*   Anti-inflammatory                                                                                  Aoyama et al. (2014) \[[@B67-biomedicines-08-00003]\]

  Indigowood Root (*Isatis indigotica Fort.*)                                                                                                                                 Anti-inflammatory                                                                                  You et al. (2009) \[[@B69-biomedicines-08-00003]\]

  Topical Honey                                                                                                                                                               Anti-inflammatory, anti-microbial, and wound healing                                               Khanal et al. (2010) \[[@B75-biomedicines-08-00003]\]

  *Hippophae rhamnoides L.* plant                                                                                                                                             Anti-oxidant, anti-ulcerogenic, anti-inflammatory, anti-microbial, and proinflammatory cytokine\   Kuduban et al. (2016) \[[@B76-biomedicines-08-00003]\]
                                                                                                                                                                              Antagonist                                                                                         

  Honey from the clover plant *Trifolium alexandrenum*                                                                                                                        Anti-microbial                                                                                     Rashad et al. (2009) \[[@B78-biomedicines-08-00003]\]

  Qingre Liyan decoction                                                                                                                                                      Anti-oxidant and anti-inflammatory                                                                 Lambros et al. (2014) \[[@B79-biomedicines-08-00003]\]

  Hangeshashinto                                                                                                                                                              Anti-inflammatory and anti-microbial                                                               Kono et al. (2014) \[[@B65-biomedicines-08-00003]\]

  Chamomile                                                                                                                                                                   Anti-inflammatory, anti-bacterial,\                                                                Fidler et al. (1996) \[[@B64-biomedicines-08-00003]\]
                                                                                                                                                                              and antifungal                                                                                     

  *Rhodila algida*                                                                                                                                                            Anti-oxidant and immunostimulant                                                                   Loo et al. (2010) \[[@B80-biomedicines-08-00003]\]

  Qingre Liyan Decoction                                                                                                                                                      Enhancing body immunity and promoting salivary EGF                                                 Wu et al. (2007) \[[@B81-biomedicines-08-00003]\]

  Chamomile                                                                                                                                                                   Anti-inflammatory, anti-bacterial,\                                                                Pourdeghatkar et al. (2017) \[[@B66-biomedicines-08-00003]\]
                                                                                                                                                                              and anti-fungal                                                                                    

  Pure Honey                                                                                                                                                                  Anti-bacterial and anti-inflammatory                                                               Motallebnejad et al. (2008) \[[@B77-biomedicines-08-00003]\]

  *Aloe vera*                                                                                                                                                                 Anti-inflammatory, anti-bacterial,\                                                                Puataweepong et al. (2009) \[[@B82-biomedicines-08-00003]\]
                                                                                                                                                                              and anti-fungal                                                                                    

  *Aloe vera* and vitamin E                                                                                                                                                   Antioxidant, anti-inflammatory, and healing properties                                             Cuba et al. (2015) \[[@B83-biomedicines-08-00003]\]

  Traumeel S                                                                                                                                                                  Anti-inflammatory                                                                                  Sencer et al. (2012) \[[@B84-biomedicines-08-00003]\]

  *Chamomilla recutita*                                                                                                                                                       Anti-inflammatory                                                                                  Braga et al. (2015) \[[@B85-biomedicines-08-00003]\]

  Wild chamomile *(Matricaria recutita L.)*                                                                                                                                   Anti-inflammatory, anti-bacterial,\                                                                Mazokopakis et al. (2003) \[[@B65-biomedicines-08-00003]\]
                                                                                                                                                                              and anti-fungal                                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
